Posted On:
March 28, 2008
New York Times Addresses Preemption Concerns Led to Alaska Settlement of Zyprexa Claim
Just a quick follow up to the previous post on preemption. The New York Times today had an article about the recent settlement by the State of Alaska regarding its suit against Eli Lilly on the drug Zyprexa and how the preemption concern is one of the main reasons Alaska decided to settle during the trial. This is a real issue with significant potential for affecting the future of our jury system of justice. When the federal government, regulatory agencies and corporate America are free to pursue their own selfish goals, we as Americans can only be on one side....the losing side.
Bookmark: 
